- Home
- EDUC vs TRAW Comparison
EDUC vs TRAW Comparison
Compare EDUC & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- TRAW
- Stock Information
- Founded
- EDUC 1965
- TRAW 1998
- Country
- EDUC United States
- TRAW United States
- Employees
- EDUC N/A
- TRAW N/A
- Industry
- EDUC Consumer Specialties
- TRAW
- Sector
- EDUC Consumer Discretionary
- TRAW
- Exchange
- EDUC Nasdaq
- TRAW NYSE
- Market Cap
- EDUC 16.6M
- TRAW 15.0M
- IPO Year
- EDUC N/A
- TRAW 2013
- Fundamental
- Price
- EDUC $1.82
- TRAW $4.51
- Analyst Decision
- EDUC
- TRAW
- Analyst Count
- EDUC 0
- TRAW 0
- Target Price
- EDUC N/A
- TRAW N/A
- AVG Volume (30 Days)
- EDUC 6.9K
- TRAW 8.5K
- Earning Date
- EDUC 01-09-2025
- TRAW 11-14-2024
- Dividend Yield
- EDUC N/A
- TRAW N/A
- EPS Growth
- EDUC N/A
- TRAW N/A
- EPS
- EDUC N/A
- TRAW N/A
- Revenue
- EDUC $42,415,800.00
- TRAW $226,000.00
- Revenue This Year
- EDUC N/A
- TRAW $2.90
- Revenue Next Year
- EDUC N/A
- TRAW N/A
- P/E Ratio
- EDUC N/A
- TRAW N/A
- Revenue Growth
- EDUC N/A
- TRAW N/A
- 52 Week Low
- EDUC $0.80
- TRAW $4.16
- 52 Week High
- EDUC $2.95
- TRAW $27.50
- Technical
- Relative Strength Index (RSI)
- EDUC 30.95
- TRAW 34.67
- Support Level
- EDUC $1.87
- TRAW $4.16
- Resistance Level
- EDUC $2.11
- TRAW $5.96
- Average True Range (ATR)
- EDUC 0.09
- TRAW 0.35
- MACD
- EDUC -0.01
- TRAW -0.03
- Stochastic Oscillator
- EDUC 12.12
- TRAW 19.44
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.